Brief: AstraZeneca To Acquire Fusion For $2 Bln In Cash

Fusion Pharmaceuticals

19/03/2024 07:42

March 19 (Reuters) - AstraZeneca PLC  AZN.L :
    * ASTRAZENECA TO ACQUIRE FUSION
    * PROPOSED DEAL FOR $21.00 PER SHARE IN CASH
    * PROPOSED DEAL FOR APPROXIMATELY $2BN
    * TO BUY FUSION FOR PRICE OF $21.00 PER SHARE IN CASH AT
CLOSING
PLUS A NON-TRANSFERABLE CONTINGENT VALUE RIGHT OF $3.00 PER
SHARE
    * WILL ACQUIRE CASH, CASH EQUIVALENTS AND SHORT TERM
INVESTMENTS
ON FUSION'S BALANCE SHEET, WHICH TOTALLED $234M AS OF 31(ST)
DECEMBER 2023

Source text for Eikon:  ID:nRSS3850Ha 
Further company coverage:  AZN.L 

 ((Reuters.Briefs@thomsonreuters.com;;))